Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies.
News: Breast Cancer
Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.
Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.
A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk, according to a study published in Journal of the National Cancer Institute.
Vanderbilt University Medical Center is the nation’s leading recruitment site for a new study examining the effectiveness of donor nerve grafts to restore sensation to breast tissue following mastectomy and reconstruction.
Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.
Finding gives boost to fighting cancer through cell metabolism
Breast cancer patients who message their doctors about certain topics are more likely to discontinue hormone therapy than others, enabling doctors to better predict which patients are at risk of stopping their treatment early.
Immunotherapies that take off the “brakes” on the adaptive anti-tumor response have worked well in melanoma and lung cancer but less so in breast cancers. That could change.